United States · 
Who invested in HDT Bio?
HDT Bio's investors include National Institutes of Health and National Institute of Allergy and Infectious Diseases.
202420252026
$1.0MGrant$5.2MGrant
United States · Funded startup
Who invested in HDT Bio
Funding summaryUpdated 26 Oct 2026
$6.2Mraised across 2 rounds since 2023, from 2 sources
$1.0MGrant$5.2MGrant
- Latest round
- Grant, $5.2MSept 2026
- Step-upi
- 5.2×
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Grant, $1.0M Oct 2023
- Biggest round
- $5.2M Grant · Sept 2026
- Between rounds
- 2.9 years from the last two
The rounds
- Sept 2026Grant$5.2M2 returning
Source recorded
- Oct 2023Grant$1.0M2 new
Source recorded
Founders and team
From HDT Bio's own website: 1 founder, 21 on the team.
- Loren BeckChief Legal Officer
- Peter BerglundChief Development Officer
- Allie LaffertyResearch Associate II
- Alyse DouglassResearch Associate III
- Brian GrangerSenior Research Associate
- Carrie NovákAssociate Scientist
- Heather KainResearch Associate III
- Ira ColemanDirector
- James KearySenior Clinical Trial Manager
- Jannabeth BannisterSenior Funding Manager
- Jim ReedSenior Scientist
- John BallantyneDirector
- Kelli CarabelloSenior Director, Finance & Accounting
- Kiara HatzakisResearch Associate II
- Priyanka KamathSenior Program Manager
- Satoko YamaokaSenior Scientist
- Scott DelbecqSenior Scientist
- Shibbu SharmaResearch Associate III
And 3 more on the team.
AdvisersDarrick Carter
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about HDT Bio
How much has HDT Bio raised?
HDT Bio has raised $6.2M across 2 rounds since 2023.
When did HDT Bio last raise?
HDT Bio's most recent round was a Grant of $5.2M in Sept 2026.
What was HDT Bio's biggest round?
Its most recent round, $5.2M in Sept 2026, is also its largest on record.
Who backed HDT Bio first?
HDT Bio's first round on record, in Oct 2023, was backed by National Institutes of Health and National Institute of Allergy and Infectious Diseases.
What stage is HDT Bio at?
HDT Bio's latest named round is a Grant, in Sept 2026.
Where is HDT Bio based?
HDT Bio is based in the United States.
Companies like HDT Bio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.